Velázquez-Moctezuma Rodrigo, Law Mansun, Bukh Jens, Prentoe Jannick
Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Department of Immunology, The Scripps Research Institute, La Jolla, California, United States of America.
PLoS Pathog. 2017 Feb 23;13(2):e1006214. doi: 10.1371/journal.ppat.1006214. eCollection 2017 Feb.
Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. With 3-4 million new HCV infections yearly, a vaccine is urgently needed. A better understanding of virus escape from neutralizing antibodies and their corresponding epitopes are important for this effort. However, for viral isolates with high antibody resistance, or antibodies with moderate potency, it remains challenging to induce escape mutations in vitro. Here, as proof-of-concept, we used antibody-sensitive HVR1-deleted (ΔHVR1) viruses to generate escape mutants for a human monoclonal antibody, AR5A, targeting a rare cross-genotype conserved epitope. By analyzing the genotype 1a envelope proteins (E1/E2) of recovered Core-NS2 recombinant H77/JFH1ΔHVR1 and performing reverse genetic studies we found that resistance to AR5A was caused by substitution L665W, also conferring resistance to the parental H77/JFH1. The mutation did not induce viral fitness loss, but abrogated AR5A binding to HCV particles and intracellular E1/E2 complexes. Culturing J6/JFH1ΔHVR1 (genotype 2a), for which fitness was decreased by L665W, with AR5A generated AR5A-resistant viruses with the substitutions I345V, L665S, and S680T, which we introduced into J6/JFH1 and J6/JFH1ΔHVR1. I345V increased fitness but had no effect on AR5A resistance. L665S impaired fitness and decreased AR5A sensitivity, while S680T combined with L665S compensated for fitness loss and decreased AR5A sensitivity even further. Interestingly, S680T alone had no fitness effect but sensitized the virus to AR5A. Of note, H77/JFH1L665S was non-viable. The resistance mutations did not affect cell-to-cell spread or E1/E2 interactions. Finally, introducing L665W, identified in genotype 1, into genotypes 2-6 parental and HVR1-deleted variants (not available for genotype 4a) we observed diverse effects on viral fitness and a universally pronounced reduction in AR5A sensitivity. Thus, we were able to take advantage of the neutralization-sensitive HVR1-deleted viruses to rapidly generate escape viruses aiding our understanding of the divergent escape pathways used by HCV to evade AR5A.
丙型肝炎病毒(HCV)是终末期肝病的主要病因。每年有300万至400万新发HCV感染病例,因此迫切需要一种疫苗。更好地了解病毒如何逃避中和抗体及其相应表位对于这一努力至关重要。然而,对于具有高抗体抗性的病毒分离株或效力中等的抗体,在体外诱导逃逸突变仍然具有挑战性。在此,作为概念验证,我们使用对抗体敏感的HVR1缺失(ΔHVR1)病毒来生成针对人单克隆抗体AR5A的逃逸突变体,AR5A靶向一种罕见的跨基因型保守表位。通过分析回收的Core-NS2重组H77/JFH1ΔHVR1的1a基因型包膜蛋白(E1/E2)并进行反向遗传学研究,我们发现对AR5A的抗性是由L665W取代引起的,这也赋予了对亲本H77/JFH1的抗性。该突变未导致病毒适应性丧失,但消除了AR5A与HCV颗粒和细胞内E1/E2复合物的结合。培养J6/JFH1ΔHVR1(2a基因型),其适应性因L665W而降低,与AR5A一起培养产生了具有I345V、L665S和S680T取代的AR5A抗性病毒,我们将这些取代引入J6/JFH1和J6/JFH1ΔHVR1。I345V提高了适应性,但对AR5A抗性没有影响。L665S损害了适应性并降低了对AR5A的敏感性,而S680T与L665S结合补偿了适应性损失并进一步降低了对AR5A的敏感性。有趣的是,单独的S680T对适应性没有影响,但使病毒对AR5A敏感。值得注意的是,H77/JFH1L665S不可存活。抗性突变不影响细胞间传播或E1/E2相互作用。最后,将在1基因型中鉴定出的L665W引入2-6基因型亲本和HVR1缺失变体(4a基因型不可用),我们观察到对病毒适应性有不同影响,并且对AR5A敏感性普遍显著降低。因此,我们能够利用对中和敏感的HVR1缺失病毒快速产生逃逸病毒,这有助于我们理解HCV用于逃避AR5A的不同逃逸途径。